default author photo

Weifang Zeng

Sichuan Haisco Pharmaceutical Co Ltd

SCHOLARLY PAPERS

1

DOWNLOADS

49

TOTAL CITATIONS

0

Scholarly Papers (1)

1.

Safety and Effectiveness of HSK21542 for Hemodialysis Patients: A Multiple Ascending Dose Study

Number of pages: 34 Posted: 03 Feb 2023
Southeast University - Institute of Nephrology, Southeast University - Institute of Nephrology, Sichuan University - Kidney Research Institute, Qingdao University - Department of Nephrology, China Medical University - Department of Nephrology, People’s Hospital of Guangxi Zhuang Autonomous Region - Department of Nephrology, Government of the People's Republic of China - Kidney Institute, Zhengzhou University - Department of Nephrology, Xuzhou Medical University - Department of Nephrology, Xiamen University - Division of Nephrology, Nanchang University - Department of Nephrology, Wuhan University - Department of Nephrology, Central South University - Division of Nephrology, Sichuan Haisco Pharmaceutical Co Ltd, Sichuan Haisco Pharmaceutical Co Ltd, Guizhou Medical University (Guiyang Medical University) - Department of Nephrology and Southeast University - Institute of Nephrology
Downloads 49 (1,086,013)

Abstract:

Loading...

CKD-aP, HSK21542, hemodialysis, κ-opioid receptor agonist, uremic pruritus